Related Experiment Video
Updated: Jan 21, 2026

Measuring Progressive Neurological Disability in a Mouse Model of Multiple Sclerosis
Published on: November 14, 2016
Mitochondrial functionality and metabolism in T cells from progressive multiple sclerosis patients
Sara De Biasi1, Anna Maria Simone2, Elena Bianchini3
1Department of Life Sciences, University of Modena and Reggio Emilia, Modena, Italy.
Patients with progressive multiple sclerosis (MS) show immune cell metabolic differences. Primary progressive MS T cells have lower mitochondrial function and higher glycolysis compared to secondary progressive MS T cells.
Area of Science:
- Immunology
- Metabolic pathways
- Neuroimmunology
Background:
- Progressive multiple sclerosis (MS) involves sustained peripheral immune activation, particularly with Th1, T cytotoxic type-1, and Th17 cells.
- T cell function and activation are intrinsically linked to their metabolic state.
Purpose of the Study:
- To investigate mitochondrial functionality and metabolic alterations in T cell subpopulations from patients with progressive MS.
- To compare metabolic profiles between primary progressive (PP) and secondary progressive (SP) MS.
Main Methods:
- Analysis of T cell subpopulations from progressive MS patients.
- Assessment of mitochondrial respiration (Oxygen Consumption Rate, Extracellular Acidification Rate), mitochondrial mass, membrane potential, and gene expression related to metabolism and T cell differentiation.
- Quantification of Glucose transporter-1 levels.
Main Results:
- T cells in progressive MS patients exhibited reduced proliferation and an increase in terminally differentiated/exhausted cells.
- T cells from PP MS patients displayed lower mitochondrial respiration and mass compared to SP MS patients.
- PP MS T cells showed a greater shift towards glycolysis, with higher Glucose transporter-1 expression and glycolytic gene upregulation compared to SP MS.
Conclusions:
- Significant phenotypic and metabolic differences exist between T cells in PP MS and SP MS patients.
- These findings highlight distinct T cell metabolic profiles within the progressive MS spectrum, despite clinical similarities.
Related Concept Videos
Pharmacokinetics in Pediatric Patients: Drug Metabolism
Animal Mitochondrial Genetics
Pharmacokinetics in Geriatric Patients: Effect of Age on Drug Metabolism
Pharmacokinetics in Obese Patients: Drug Metabolism and Excretion
What is Metabolism?
Export of Mitochondrial and Chloroplast Genes

